About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 19 Issue 4 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1819 results:

Short communication

A decade of HIV-1 drug resistance in the United States: trends and characteristics in a large protease/reverse transcriptase and co-receptor tropism database from 2003 to 2012

Agnes C Paquet, Owen D Solberg, Laura A Napolitano, Joseph M Volpe, Charles Walworth, Jeannette M Whitcomb, Christos J Petropoulos, Mojgan Haddad

Antiviral Therapy 2014; 19:435-441


Short communication

CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1–HBV coinfection following HBV-active antiretroviral therapy

Paola Giarda, Anchalee Avihingsanon, Joe Sasadeusz, Jennifer Audsley, Pip Marks, Gail Matthews, Kiat Ruxrungtham, Sharon R Lewin, Megan Crane

Antiviral Therapy 2014; 19:429-433


Short communication

Presence of anti-interferon antibodies is not associated with non-response to pegylated interferon treatment in chronic hepatitis B

Pauline Arends, Annemiek A van der Eijk, Milan J Sonneveld, Bettina E Hansen, Harry LA Janssen, Bart L Haagmans

Antiviral Therapy 2014; 19:423-427


Original article

Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C

Christopher B Hurt, Sonia Napravnik, Richard D Moore, Joseph J Eron

Antiviral Therapy 2014; 19:415-422


Original article

Strategies for assignment of HIV–HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

Mattias Mandorfer, Karin Neukam, Antonio Rivero, Massimo Puoti, Christoph Boesecke, Axel Baumgarten, Anna Grzeszczuk, Robert Zangerle, Diana Ernst, Jürgen Kurt Rockstroh, Michael Trauner, Juan Antonio Pineda, Markus Peck-Radosavljevic, Thomas Reiberger

Antiviral Therapy 2014; 19:407-414


Original article

Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen

Retsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, Sandra Meredith, Lubbe Wiesner, Ashraf Coovadia, Renate Strehlau, Leigh Martens, Elaine J Abrams, Gary Maartens, Helen McIlleron

Antiviral Therapy 2014; 19:399-406


Original article

Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000–2010

Sayonara R Ribeiro, Paula M Luz, Dayse P Campos, Ronaldo I Moreira, Lara Coelho, André Japiassu, Fernando Bozza, Valdilea G Veloso, Genevieve Chene, Beatriz Grinsztejn

Antiviral Therapy 2014; 19:387-397


Original article

Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network Cohort

María Jesús Pérez-Elías, Alfonso Muriel, Ana Moreno, María Martinez-Colubi, José A Iribarren, Mar Masiá, José R Blanco, Rosario Palacios, Jorge del Romero, Desire G Pérez, Victoria Hernando, CoRIS Study Group

Antiviral Therapy 2014; 19:375-385


Original article

Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes

Carol Crowther, Mohube B Mowa, Abdullah Ely, Patrick B Arbuthnot

Antiviral Therapy 2014; 19:363-373


Free
Original article

Intravenous peramivir for treatment of influenza in hospitalized patients

Michael G Ison, Joseph Fraiz, Barry Heller, Luis Jauregui, Graham Mills, William O’Riordan, Brian O’Neil, E Geoffrey Playford, J Douglass Rolf, Eduardo Sada-Diaz, Jenna Elder, Phil Collis, Jaime E Hernandez, William P Sheridan

Antiviral Therapy 2014; 19:349-361


Page:
Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.